By Drug Target Review2025-02-27T09:00:18
Researchers have identified a small gene, SCN10a-short, that could enable gene therapy to treat malignant cardiac arrhythmias. This discovery offers the potential for a one-time treatment, reducing the reliance on lifelong medication and invasive procedures.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-11-20T13:43:43
Sponsored by Merck
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
Site powered by Webvision Cloud